Literature DB >> 2649189

HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

J Knüver-Hopf1, H Mohr, J Beyer, B Lambrecht, D Mix, H Rübsamen-Waigmann, H Schmitt.   

Abstract

Antibodies against human immunodeficiency virus type-1 (HIV-1) in samples from blood donors are commonly detected by various enzyme-linked immunosorbent assays (ELISA) and by confirmatory tests, e.g., "Western blot" or immunofluorescence tests. Immunoblot reactivity, which is directed only towards the HIV-1 core proteins p 18, p 24 and p 55, may represent false-positive reactions. Out of 125,000 blood donations, 140 were repeatably HIV-1 antibody reactive by ELISA; of these, 20 were doubtful positive sera with isolated p 18 and/or p 24 bands in the HIV-1 confirmatory assay. Antibodies to HIV-2 are known to cross-react with these HIV-1 core proteins. We therefore assayed the 20 sera by immunofluorescence and immunoblotting for the presence of antibodies to HIV-2. None of these doubtful HIV-1 antibody positive blood donor sera was found to have antibodies to HIV-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649189     DOI: 10.1007/bf00320437

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Relationship of AIDS to other retroviruses.

Authors:  S Wain-Hobson; M Alizon; L Montagnier
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

2.  [Prevalence of HIV antibodies in blood donors in the West Germany and West Berlin].

Authors:  D Glück; K Koerner; G Caspari; G Elbert; W Grässmann; R Hesse; G Holzberger; B Kostuch; J Sternberger; A Vornwald
Journal:  Dtsch Med Wochenschr       Date:  1987-10-16       Impact factor: 0.628

3.  HIV-specific antibody among voluntary blood donors in Lower Saxony (FRG).

Authors:  G Caspari; J Beyer; F Schunter; J Knüver-Hopf; H Schmitt
Journal:  Blut       Date:  1987-09

4.  False-positive Western blot reactions to human immunodeficiency virus in blood donors.

Authors:  A M Couroucé; J Y Muller; D Richard
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

5.  The global distribution of human immunodeficiency virus type 2 (HIV-2) infection.

Authors:  C R Horsburgh; S D Holmberg
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

6.  Molecular cloning and polymorphism of the human immune deficiency virus type 2.

Authors:  F Clavel; M Guyader; D Guétard; M Sallé; L Montagnier; M Alizon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

7.  Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

Authors:  M A Gonda; F Wong-Staal; R C Gallo; J E Clements; O Narayan; R V Gilden
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

8.  Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.

Authors:  J I Esteban; J W Shih; C C Tai; A J Bodner; J W Kay; H J Alter
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

9.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

10.  Antibody response in primary human immunodeficiency virus infection.

Authors:  H Gaines; M von Sydow; A Sönnerborg; J Albert; J Czajkowski; P O Pehrson; F Chiodi; L Moberg; E M Fenyö; B Asjö
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.